These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of weight gain induced by antipsychotic drugs. Baptista T J Clin Psychiatry; 2002 Mar; 63(3):245-6. PubMed ID: 11926725 [No Abstract] [Full Text] [Related]
6. [Atypical antipsychotic induced weight gain and metabolic disorders]. Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331 [TBL] [Abstract][Full Text] [Related]
7. [Metabolic risk during antipsychotic treatment in patients with schizophrenia]. Rzewuska M Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977 [TBL] [Abstract][Full Text] [Related]
8. Risperidone-associated steatohepatitis and excessive weight-gain. Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356 [TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotic drugs, diabetes and ethnicity. Ananth J; Kolli S; Gunatilake S; Brown S Expert Opin Drug Saf; 2005 Nov; 4(6):1111-24. PubMed ID: 16255668 [TBL] [Abstract][Full Text] [Related]
10. Glucose abnormalities in a non-psychotic patient treated with risperidone. Lauwers K; De Hert M J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):629-30. PubMed ID: 15968229 [No Abstract] [Full Text] [Related]
12. Consensus development conference on antipsychotic drugs and obesity and diabetes. ; ; ; Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231 [No Abstract] [Full Text] [Related]
13. Risperidone-associated newly diagnosed diabetes and fatal diabetes ketoacidosis in a young schizophrenic patient. Lu CH; Yan YH Diabetes Res Clin Pract; 2009 Feb; 83(2):e66-7. PubMed ID: 19135753 [TBL] [Abstract][Full Text] [Related]
14. Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men. Gross C; Blasey CM; Roe RL; Belanoff JK Obesity (Silver Spring); 2010 Dec; 18(12):2295-300. PubMed ID: 20339369 [TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities]. Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734 [TBL] [Abstract][Full Text] [Related]
16. [Risperidone and edema: apropos of a case]. Masson M; Elayli R; Verdoux H Encephale; 2000; 26(3):91-2. PubMed ID: 10951912 [No Abstract] [Full Text] [Related]
17. Antipsychotic drugs: the weight problem. Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878 [No Abstract] [Full Text] [Related]
18. Weight gain with risperidone. Brecher M; Geller W J Clin Psychopharmacol; 1997 Oct; 17(5):435-6. PubMed ID: 9316002 [No Abstract] [Full Text] [Related]
19. Diet and the atypical neuroleptics. Horrigan JP; Sikich L J Am Acad Child Adolesc Psychiatry; 1998 Nov; 37(11):1126-7. PubMed ID: 9808916 [No Abstract] [Full Text] [Related]
20. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder. Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456 [No Abstract] [Full Text] [Related] [Next] [New Search]